World's Best Scientists 2026 revealed!
VIEW LIST
Javier Cortes

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 99 8427 7919 121 118 577 53681

Javier Cortes publications per year

The chart shows the history of publications by Javier Cortes between 1988 and 2026, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Javier Cortes published across 39 years, from 1988 to 2026, averaging 31.1 papers a year. Output peaked at 320 publications in 2023. 95 of the 1,211 publications appeared in the last two years.

No. of publications
100 200 300
Bar chart. Horizontal axis: year, 1988 to 2026. Vertical axis: number of publications, 0 to 320. Peak 320 publications in 2023. 1988: 1 publication 1989: 0 publications 1990: 1 publication 1991: 0 publications 1992: 0 publications 1993: 0 publications 1994: 0 publications 1995: 0 publications 1996: 0 publications 1997: 0 publications 1998: 0 publications 1999: 0 publications 2000: 0 publications 2001: 2 publications 2002: 3 publications 2003: 1 publication 2004: 1 publication 2005: 4 publications 2006: 4 publications 2007: 6 publications 2008: 6 publications 2009: 12 publications 2010: 20 publications 2011: 15 publications 2012: 42 publications 2013: 48 publications 2014: 45 publications 2015: 55 publications 2016: 37 publications 2017: 38 publications 2018: 48 publications 2019: 43 publications 2020: 78 publications 2021: 70 publications 2022: 90 publications 2023: 320 publications 2024: 126 publications 2025: 93 publications 2026: 2 publications
1988 2026

1,211 publications in total across all disciplines

View publications per year as a table
Javier Cortes: publications per year, 1988 to 2026
Year Publications
1988 1
1989 0
1990 1
1991 0
1992 0
1993 0
1994 0
1995 0
1996 0
1997 0
1998 0
1999 0
2000 0
2001 2
2002 3
2003 1
2004 1
2005 4
2006 4
2007 6
2008 6
2009 12
2010 20
2011 15
2012 42
2013 48
2014 45
2015 55
2016 37
2017 38
2018 48
2019 43
2020 78
2021 70
2022 90
2023 320
2024 126
2025 93
2026 2
Total 1,211
Download as CSV

Javier Cortes publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Javier Cortes sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 561–580 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 577 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504 577
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Javier Cortes D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Javier Cortes sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668 99
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Javier Cortes is affiliated with Vall d'Hebron Hospital Universitari in Spain and has published extensively in the medical field, particularly focusing on oncology and breast cancer research.

Their research primarily spans the fields of Medicine, with 1,148 publications, and Biochemistry, Genetics, and Molecular Biology, covering 293 works. Key subfields include Oncology (655 publications), Pulmonary and Respiratory Medicine (295), Cancer Research (202), Radiology, Nuclear Medicine and Imaging (88), and Molecular Biology (63). This range highlights a broad engagement with clinical and molecular aspects of cancer research.

The main topics explored in their work include:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Breast Cancer Treatment Studies
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Monoclonal and Polyclonal Antibodies Research

Among their frequent co-authors are Antonio Llombart-Cussac, Hope S. Rugo, José Manuel Pérez-García, Giuseppe Curigliano, and Peter Schmid, indicating a collaborative research network in oncology and breast cancer treatment.

Javier Cortes has contributed to several notable papers, including:

  • "Pembrolizumab for Early Triple-Negative Breast Cancer" (2020) published in New England Journal of Medicine
  • "Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial" (2020) published in The Lancet
  • "Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer" (2021) published in New England Journal of Medicine
  • "5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)" (2020) published in Annals of Oncology
  • "ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer" (2021) published in Annals of Oncology

The most frequent publication venues for Javier Cortes include Cancer Research, Annals of Oncology, Journal of Clinical Oncology, ESMO Open, and Clinical Cancer Research, reflecting a focus on cancer and oncology-centric journals.

In addition to research articles, they have contributed to book publications such as "Por una nueva historia de la familia en México" (2024) published by Universidad Autónoma de Aguascalientes eBooks.

Best Publications

  • Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

    José Baselga;Javier Cortés;Sung-Bae Kim;Seock-Ah Im

  • Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer

    Sandra M. Swain;José Baselga;Sung-Bae Kim;Jungsil Ro

  • Pembrolizumab for Early Triple-Negative Breast Cancer.

    Peter Schmid;Javier Cortes;Lajos Pusztai;Heather McArthur

  • Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

    Shanu Modi;Cristina Saura;Toshinari Yamashita;Yeon Hee Park

  • Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer

    Aditya Bardia;Sara A Hurvitz;Sara M Tolaney;Delphine Loirat

  • Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.

    Javier Cortes;David W Cescon;Hope S Rugo;Zbigniew Nowecki

  • Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)

    A. Schneeweiss;S. Chia;T. Hickish;V. Harvey

  • Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

    David W. Miles;Arlene Chan;Luc Y. Dirix;Javier Cortés

  • Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): A phase 3 open-label randomised study

    Javier Cortes;Joyce O'Shaughnessy;David Loesch;Joanne J.L. Blum

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

    Sandra M Swain;Sung-Bae Kim;Javier Cortés;Jungsil Ro

  • Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer

    Maurizio Scaltriti;Federico Rojo;Alberto Ocaña;Judit Anido

  • Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy

    José Baselga;Karen A. Gelmon;Shailendra Verma;Andrew Wardley

  • Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

    Leticia De Mattos-Arruda;Leticia De Mattos-Arruda;Leticia De Mattos-Arruda;Regina Mayor;Charlotte K. Y. Ng;Britta Weigelt

  • Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study.

    Sylvia Adams;Peter Schmid;Hope H.S. Rugo;Eric Winer

  • Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

    Sandra M Swain;Sandra M Swain;David Miles;Sung-Bae Kim;Young-Hyuck Im

  • Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.

    Maria Teresa Herrera-Abreu;Marta Palafox;Uzma Asghar;Martín A Rivas

  • MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer

    Maura N. Dickler;Sara Tolaney;Hope S. Rugo;Javier Cortés

  • PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition

    Yasir H. Ibrahim;Celina García-García;Violeta Serra;Lei He

  • Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial

    José Baselga;Seock Ah Im;Hiroji Iwata;Javier Cortés

  • The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

    Luping Lin;Amit J Sabnis;Elton Chan;Victor Olivas

Frequent Co-Authors

José Baselga
José Baselga Memorial Sloan Kettering Cancer Center
Hope S. Rugo
Hope S. Rugo University of California, San Francisco
Ahmad Awada
Ahmad Awada Université Libre de Bruxelles
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Joyce O'Shaughnessy
Joyce O'Shaughnessy Baylor University Medical Center
Seock-Ah Im
Seock-Ah Im Seoul National University Hospital
Véronique Diéras
Véronique Diéras Institute Curie
Aleix Prat
Aleix Prat University of Barcelona
Paolo Nuciforo
Paolo Nuciforo Vall d´Hebron Institute of Oncology
Joan Seoane
Joan Seoane Institució Catalana de Recerca i Estudis Avançats

External Links

Personal website of Javier Cortes

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a future in medicine isn’t limited to the traditional path of becoming a physician. Many related healthcare degrees and career options are available online, offering flexible entry points and faster progression for those seeking to make a difference in healthcare.

For experienced nurses aiming to reach the highest levels of clinical nursing practice, shortest dnp programs provide a streamlined way to earn a Doctor of Nursing Practice in less time. Those who prefer manageable coursework can consider easiest online dnp programs, which balance academic rigor with supportive learning environments.

Entry-level options like lpn programs are ideal for those who want to quickly begin working in the medical field as Licensed Practical Nurses. Meanwhile, for nurses interested in mental health, accelerated msn psychiatric np programs offer a fast track to becoming a specialized nurse practitioner.

Each of these online pathways offers a unique route to impactful, rewarding medical careers for diverse backgrounds and goals.

Best Scientists Citing Javier Cortes

Giuseppe Curigliano

Giuseppe Curigliano

University of Milan

Publications: 102

José Baselga

José Baselga

Memorial Sloan Kettering Cancer Center

Publications: 87

Hope S. Rugo

Hope S. Rugo

University of California, San Francisco

Publications: 83

Eric P. Winer

Eric P. Winer

Yale University

Publications: 74

Sherene Loi

Sherene Loi

Peter MacCallum Cancer Centre

Publications: 73

Fabrice Andre

Fabrice Andre

Institut Gustave Roussy

Publications: 73

Evandro de Azambuja

Evandro de Azambuja

Université Libre de Bruxelles

Publications: 70

Nadia Harbeck

Nadia Harbeck

Ludwig-Maximilians-Universität München

Publications: 65

Martine Piccart

Martine Piccart

Université Libre de Bruxelles

Publications: 64

Nicholas C. Turner

Nicholas C. Turner

Royal Marsden NHS Foundation Trust

Publications: 61

Mario Campone

Mario Campone

Grenoble Alpes University

Publications: 61

Ian E. Krop

Ian E. Krop

Harvard University

Publications: 61

Sibylle Loibl

Sibylle Loibl

Goethe University Frankfurt

Publications: 57

Volkmar Müller

Volkmar Müller

Universität Hamburg

Publications: 57

Andreas Schneeweiss

Andreas Schneeweiss

German Cancer Research Center

Publications: 56

Sara A. Hurvitz

Sara A. Hurvitz

Fred Hutchinson Cancer Research Center

Publications: 55

Trending Scientists

Marc Ilegems

Marc Ilegems

École Polytechnique Fédérale de Lausanne

Cyril Luxey

Cyril Luxey

Université Côte d'Azur

Susie Chandler

Susie Chandler

King's College London

David Coghill

David Coghill

University of Melbourne

Tore Midtvedt

Tore Midtvedt

Karolinska Institute

Michael M. Merzenich

Michael M. Merzenich

University of California, San Francisco

Eckardt Treuter

Eckardt Treuter

Karolinska Institute

Jianjun Li

Jianjun Li

Chinese Academy of Sciences

Phillip A. Sharp

Phillip A. Sharp

MIT

Walter Mérida

Walter Mérida

University of British Columbia

Marco Lops

Marco Lops

University of Naples Federico II

Qunxiong Zhu

Qunxiong Zhu

Beijing University of Chemical Technology

Farhad Soleimanian Gharehchopogh

Farhad Soleimanian Gharehchopogh

Islamic Azad University, Tehran

Paul J. Fagan

Paul J. Fagan

DuPont (United States)

Stephen F. Witt

Stephen F. Witt

University of Surrey

Ernesto Stein

Ernesto Stein

Inter-American Development Bank

Related Medicine Rankings & Guides

2027 Healthcare Degree Programs You Can Earn in 2 Years or Less

2027 Healthcare Degree Programs You Can Earn in 2 Years or Less
2027 Best Online Associate in Sonography Programs

2027 Best Online Associate in Sonography Programs
2027 Best Online RN to BSN Programs Without Statistics

2027 Best Online RN to BSN Programs Without Statistics
2027 Fastest Online Surgical Tech Certificate Programs

2027 Fastest Online Surgical Tech Certificate Programs
2027 Most Affordable Online LVN Programs

2027 Most Affordable Online LVN Programs
2027 Most Affordable Master’s in Health Science Degrees

2027 Most Affordable Master’s in Health Science Degrees
2027 Easiest RN-to-BSN Online Programs

2027 Easiest RN-to-BSN Online Programs
2027 Medical Lab Tech Programs Online: Best Schools

2027 Medical Lab Tech Programs Online: Best Schools
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Best Online Medical Assistant Associate Degree Programs

2027 Best Online Medical Assistant Associate Degree Programs
2027 Most Affordable Online Associate’s Degree in Radiology

2027 Most Affordable Online Associate’s Degree in Radiology
2027 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in North Carolina – Accredited Schools Online & Campus
September 2027 Best Online Doctorate in Healthcare Management Programs

September 2027 Best Online Doctorate in Healthcare Management Programs
2027 Best Online Bachelor’s Degrees in Nutritional Science Programs

2027 Best Online Bachelor’s Degrees in Nutritional Science Programs
2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference

2027 Medical Billing and Coding Certificate vs. Bachelor's Degree: Explaining the Difference
2027 Best Shortest Online Post-Master's FNP Certificate Programs

2027 Best Shortest Online Post-Master's FNP Certificate Programs
2026 Best RN to BSN Programs With No Clinicals

2026 Best RN to BSN Programs With No Clinicals
2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in New Jersey – Accredited Schools Online & Campus
2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Wisconsin – Accredited Schools Online & Campus
2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Texas – Accredited RN to BSN Programs
2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

2027 Best Pharmacy Schools & Pharmacist Programs Requirements in Oklahoma: Online & Campus

Recently Published Articles

2027 Sports Management Careers: Skills, Education, Salary & Job Outlook

2027 Sports Management Careers: Skills, Education, Salary & Job Outlook
2027 Economics Degree Master's Programs You Can Start Without Meeting All Requirements

2027 Economics Degree Master's Programs You Can Start Without Meeting All Requirements
2027 Master's in Social Work vs. Clinical Mental Health Counseling: Explaining the Difference

2027 Master's in Social Work vs. Clinical Mental Health Counseling: Explaining the Difference
2027 How to Become a Policy Analyst: Education, Salary, and Job Outlook

2027 How to Become a Policy Analyst: Education, Salary, and Job Outlook
2027 ESL Teacher Requirements & ESOL Certification in Michigan

2027 ESL Teacher Requirements & ESOL Certification in Michigan
2027 How to Become a Mental Health Counselor in Mesa, AZ: Education Requirements & Certification

2027 How to Become a Mental Health Counselor in Mesa, AZ: Education Requirements & Certification
2027 How to Become a Transport Manager: Education, Salary, and Job Outlook

2027 How to Become a Transport Manager: Education, Salary, and Job Outlook
2027 Organizational Psychology Careers: Guide to Career Paths, Options & Salaries

2027 Organizational Psychology Careers: Guide to Career Paths, Options & Salaries
2027 Best Online Nursing Programs in North Carolina – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in North Carolina – Accredited RN to BSN Programs
2027 Is an International Business Master's Degree Worth It? ROI, Salary & Career Impact

2027 Is an International Business Master's Degree Worth It? ROI, Salary & Career Impact
2027 How to Become a Psychiatric Technician: Education, Salary, and Job Outlook

2027 How to Become a Psychiatric Technician: Education, Salary, and Job Outlook
2027 Is a Degree in Social Work Worth It?

2027 Is a Degree in Social Work Worth It?
2027 Most Popular Concentrations in Addiction Psychology Degrees

2027 Most Popular Concentrations in Addiction Psychology Degrees
2027 Best Forensic Psychology Degree Programs in New Jersey: Online & Campus

2027 Best Forensic Psychology Degree Programs in New Jersey: Online & Campus
2027 Online Audio & Music Master's Degree Program Costs: Tuition & Fees

2027 Online Audio & Music Master's Degree Program Costs: Tuition & Fees
2027 How Many Credits Do You Need for a Business Administration Bachelor's Degree?

2027 How Many Credits Do You Need for a Business Administration Bachelor's Degree?
2027 How to Become a Forensic Scientist in Missouri

2027 How to Become a Forensic Scientist in Missouri
2027 Best Accredited Online Animal Science Bachelor's Degree Programs

2027 Best Accredited Online Animal Science Bachelor's Degree Programs
2027 Educational Psychology Degree Coursework Explained: What Classes Can You Expect to Take?

2027 Educational Psychology Degree Coursework Explained: What Classes Can You Expect to Take?
2027 Part-Time vs. Full-Time Social Work Degree Programs

2027 Part-Time vs. Full-Time Social Work Degree Programs
2027 STEM Careers: Guide to Career Paths, Options & Salary

2027 STEM Careers: Guide to Career Paths, Options & Salary